Home › Melanoma › Florida › Miami
Pag-aaral pangklinika para sa Melanoma sa Miami, FL
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Miami. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- University of Miami, Miami
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Nagre-recruitPhase 1/2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Nagre-recruitPhase 1/2
- University of Miami, Miami
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Nagre-recruitPhase 1/2
- Sylvester Comprehensive Cancer Center - Miami, Miami
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Nicklaus Children's Hospital, Miami
- Miami Cancer Institute, Miami
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Nagre-recruitPhase 1/2
- Sylvester Comprehensive Cancer Center, Miami
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Nagre-recruitPhase 1/2
- University of Miami Hospital and Clinics, Miami
A Study of VET3-TGI in Patients With Solid Tumors
Nagre-recruitPhase 1
- University of Miami, Miami
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- Sylvester Comprehensive Cancer Center, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Miami
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- University of Miami Miller School of Medicine-Sylvester Cancer Centre, Miami
- University of Miami Comprehensive Cancer Center at Kendall, Miami
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX61 pag-aaral
- New York City, NY41 pag-aaral
- Nashville, TN34 pag-aaral
- Los Angeles, CA34 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA25 pag-aaral
- St. Louis, MO23 pag-aaral
- Durham, NC22 pag-aaral
- Philadelphia, PA22 pag-aaral
- Tampa, FL21 pag-aaral
- Columbus, OH21 pag-aaral
- Dallas, TX21 pag-aaral
Iba pang pag-aaral sa Miami
- Kanser sa Suso42 pag-aaral
- Kanser (lahat ng uri)36 pag-aaral
- Non-Small Cell Lung Cancer35 pag-aaral
- Kanser sa Prostate30 pag-aaral
- Obesity28 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Overweight23 pag-aaral
- Metastatic Cancer22 pag-aaral
- Multiple Myeloma22 pag-aaral
- Kanser sa Baga22 pag-aaral
- Sakit ni Alzheimer21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.